Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > NSCLC and GBM indications

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Dec 17, 2022 12:55am

327 Views

Post# 35177319

RE:RE:NSCLC and GBM indications

Science first, you did forget to mention that Dr. Jewett who opted to be not on the board of MSAB. There is one other glaring omission of Dr. Kulkarni and Dr. Lilge who have been hands on with the clinical investigation. Yes we can add new Drs on the board, however it does not bolster the company's image.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec